These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25908720)

  • 1. Rectal hypersensitivity in patients with quiescent ulcerative colitis.
    Casanova MJ; Santander C; Gisbert JP
    J Crohns Colitis; 2015 Jul; 9(7):592. PubMed ID: 25908720
    [No Abstract]   [Full Text] [Related]  

  • 2. Anorectal manometry in active and quiescent ulcerative colitis.
    Loening-Baucke V; Metcalf AM; Shirazi S
    Am J Gastroenterol; 1989 Aug; 84(8):892-7. PubMed ID: 2756980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional study of the anorectal region in hemorrhagic rectocolitis].
    Zielinski B
    Ann Gastroenterol Hepatol (Paris); 1984; 20(5):243-8. PubMed ID: 6529181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative colitis - a 6-month placebo-controlled trial.
    Lichtenstein GR; Gordon GL; Zakko S; Murthy U; Sedghi S; Pruitt R; Merchant K; Shaw A; Bortey E; Forbes WP
    Aliment Pharmacol Ther; 2010 Oct; 32(8):990-9. PubMed ID: 20937044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.
    Sandborn WJ; Regula J; Feagan BG; Belousova E; Jojic N; Lukas M; Yacyshyn B; Krzeski P; Yeh CH; Messer CA; Hanauer SB
    Gastroenterology; 2009 Dec; 137(6):1934-43.e1-3. PubMed ID: 19766640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal vascular resistance in ulcerative colitis.
    Binder V
    Scand J Gastroenterol; 1968; 3(1):36-42. PubMed ID: 4385258
    [No Abstract]   [Full Text] [Related]  

  • 7. Infliximab for ulcerative colitis.
    Shields CJ; Winter DC
    N Engl J Med; 2006 Mar; 354(13):1424-6; author reply 1424-6. PubMed ID: 16571891
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment: Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis and the Kounis syndrome.
    Kounis GN; Kouni SA; Chiladakis JA; Kounis NG
    Ann Pharmacother; 2009 Feb; 43(2):393-4. PubMed ID: 19141654
    [No Abstract]   [Full Text] [Related]  

  • 9. Experience with mucosal proctectomy and a J-shaped ileal reservoir in ulcerative colitis.
    Taylor TV
    Ann R Coll Surg Engl; 1987 Jan; 69(1):12-5. PubMed ID: 3566110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anorectal dysfunction in patients with ulcerative colitis: impaired adaptation or enhanced perception?
    Brochard C; Siproudhis L; Ropert A; Mallak A; Bretagne JF; Bouguen G
    Neurogastroenterol Motil; 2015 Jul; 27(7):1032-7. PubMed ID: 25940976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
    Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
    Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain and mechanical properties of the rectum in patients with active ulcerative colitis.
    Drewes AM; Frøkjaer JB; Larsen E; Reddy H; Arendt-Nielsen L; Gregersen H
    Inflamm Bowel Dis; 2006 Apr; 12(4):294-303. PubMed ID: 16633051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
    Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sensitivity and distensibility of the rectal wall in ulcerative colitis].
    Denis P; Colin R; Galmiche JP; Hecketsweiler P; Pasquis P; Lefrancois R
    Gastroenterol Clin Biol; 1980 Dec; 4(12):870-4. PubMed ID: 7461399
    [No Abstract]   [Full Text] [Related]  

  • 16. Mesalamine-induced pleuritis in a patient with ulcerative colitis.
    Tozzi A; Biagini MR; Rastelli C; Galli A; Baldi D; Milani S
    Inflamm Bowel Dis; 2009 Jan; 15(1):158-9. PubMed ID: 18629902
    [No Abstract]   [Full Text] [Related]  

  • 17. Ulcerative colitis: rectal dilations in a patient with refractory diarrhea. Report of a case.
    Frieri G; Ligas E; Perugini B; Onori L; Marcheggiano A; Caprilli R
    Dis Colon Rectum; 1995 May; 38(5):545-9. PubMed ID: 7736888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elastic properties of the rectal wall in normal adults and in the patients with ulcerative colitis.
    Denis P; Colin R; Galmiche JP; Geffroy Y; Hecketsweiler P; Lefrancois R; Pasquis P
    Gastroenterology; 1979 Jul; 77(1):45-8. PubMed ID: 447026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis.
    Stelts S; Taylor MH; Nappi J; Van Bakel AB
    Ann Pharmacother; 2008 Jun; 42(6):904-5. PubMed ID: 18430794
    [No Abstract]   [Full Text] [Related]  

  • 20. Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis.
    Murphy SJ; Mayer L; Abreu MT
    J Clin Gastroenterol; 2011 Jan; 45(1):83-4. PubMed ID: 20535023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.